CA2783612A1 - Composition destinee au traitement des lesions cutanees - Google Patents

Composition destinee au traitement des lesions cutanees Download PDF

Info

Publication number
CA2783612A1
CA2783612A1 CA2783612A CA2783612A CA2783612A1 CA 2783612 A1 CA2783612 A1 CA 2783612A1 CA 2783612 A CA2783612 A CA 2783612A CA 2783612 A CA2783612 A CA 2783612A CA 2783612 A1 CA2783612 A1 CA 2783612A1
Authority
CA
Canada
Prior art keywords
copper
formulation
skin
composition according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2783612A
Other languages
English (en)
Inventor
John Spurge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DYNAMICLEAR Pty Ltd
Original Assignee
DYNAMICLEAR Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/633,599 external-priority patent/US20110064826A1/en
Application filed by DYNAMICLEAR Pty Ltd filed Critical DYNAMICLEAR Pty Ltd
Publication of CA2783612A1 publication Critical patent/CA2783612A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition destinée au traitement topique des lésions de la peau et des muqueuses, ladite composition comprenant une combinaison synergique d'un composé de cuivre et d'un extrait de Hypericum perforatum.
CA2783612A 2009-12-08 2010-11-25 Composition destinee au traitement des lesions cutanees Abandoned CA2783612A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/633,599 US20110064826A1 (en) 2005-06-20 2009-12-08 Composition for treating skin lesions
US12/633,599 2009-12-08
PCT/AU2010/001581 WO2011069184A1 (fr) 2009-12-08 2010-11-25 Composition destinée au traitement des lésions cutanées

Publications (1)

Publication Number Publication Date
CA2783612A1 true CA2783612A1 (fr) 2011-06-16

Family

ID=44145020

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2783612A Abandoned CA2783612A1 (fr) 2009-12-08 2010-11-25 Composition destinee au traitement des lesions cutanees

Country Status (2)

Country Link
CA (1) CA2783612A1 (fr)
WO (1) WO2011069184A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11007143B2 (en) * 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
AU2196195A (en) * 1994-03-28 1995-10-17 Skin Biology, Inc. Metal complexes of aloe extracts for skin and hair
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
US20040191330A1 (en) * 2003-03-31 2004-09-30 Keefe Candace R. Daily skin care regimen
AU2009217410B2 (en) * 2005-06-20 2011-07-28 Sci-Chem International Pty. Ltd. Composition for treating skin lesions
WO2008037262A1 (fr) * 2006-09-28 2008-04-03 Stormøllen A/S Composition pharmaceutique et SON utilisations

Also Published As

Publication number Publication date
WO2011069184A1 (fr) 2011-06-16

Similar Documents

Publication Publication Date Title
CA2613297C (fr) Composition pour traiter les lesions cutanees
US20110064826A1 (en) Composition for treating skin lesions
Wölbling et al. Local therapy of herpes simplex with dried extract from Melissa officinalis
ES2278393T3 (es) Tratamiento antimicrobiano del virus herpes simplex y otras enfermedades infecciosas.
US20090191288A1 (en) Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
CA2783612A1 (fr) Composition destinee au traitement des lesions cutanees
US20090220440A1 (en) Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections
US4049798A (en) Method for the treatment of Herpes Simplex
AU2009217410B2 (en) Composition for treating skin lesions
US6803056B2 (en) Method and composition for treating viral outbreaks
WO2011057363A1 (fr) Dispositif jetable et utilisations de celui-ci pour applications sur la peau et les muqueuses
US11298393B2 (en) Composition comprising a mixture of an extract and bentonite
AU2006261580B2 (en) Composition for treating skin lesions
FR2710844A1 (fr) Composition pour le traitement ou la prévention de l'herpès.
JP6830482B2 (ja) 粘膜病変の治療のための配合物
RU2241443C1 (ru) Фармацевтическая композиция для лечения герпес-вирусной инфекции
US20160106797A1 (en) Topical treatment of shingles
US20230310612A1 (en) Anti-viral composition and method for preparing the same
JP2018507895A (ja) ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
US20110229584A1 (en) Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm
EP2544669A1 (fr) Timbre adhésif pour l'administration d'un agent thérapeutique
US20160058818A1 (en) Compositions and methods for relief from cold sores
SK5161Y1 (sk) Liečivý prípravok na hojenie oparov
SK1292006A3 (sk) Liečivý prípravok na hojenie oparov

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20141125

FZDE Discontinued

Effective date: 20141125

FZDE Discontinued

Effective date: 20141125